OPL

12.5%

1.8¢ opyl limited

Ann: Opyl develops clinical trial prediction software using AI, page-22

First 22 Last

Share
Profile

Follow
Bezzzzzo

419 Posts.

71

26/02/20

21:50

Post #: 43174578
Share

Originally posted by jap356: ↑

Yeah interesting observation.
They must have ramped up the # of staff or increased the amount they are paying themselves in that first 4C and realised they are seriously kidding themselves justifying those costs.
Actual staffing costs
Quarter ended
31 Dec 2018
$375 000
31 March 2019 *strategic review
$463 000
30 June 2019*restructure and cost cutting
$255 000
30 Sep 2019
$285 000
31 Dec 2019
$300 000
Estimated Outflow staffing costs recent 4C
31 March 2020
$456 469
APPENDIX 4C - CLARIFICATION
31 March 2020
$211 000

The reduction of 31% in total administrative, staff and corporate costs mentioned in the recent business update
2018
staff 375 000 Admin & corporate $265 000 = 640 000
2019
staff 300 000 Admin & corporate $179 000 = 479 000
Costs down by 161 000

With the revised 4C they will be down on costs - if it goes by the first 4C then yes costs are back to being way up.

I am too far under to bail on this one - but I was comfortable at being at a loss when it couldnt fall any further, now it seems there is no bottom for this. As long as the sell side doesnt start to mount down bellow 0.10 it may travel back up above consolidation levels. Yesterday afternoon was a nice surprise tick up though, so maybe there is some interest.

Expand

Ahh my fault, i failed to notice the correction. Weird how they got those numbers so wrong.

393k outflow isn't bad considering they said invoices were down 24% due to invoice timing and restructuring, so it's possible they might have better quarter and be up over 300k in receipts.

Will be interesting to see how it plays out

OPL Price at posting: 8.6¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

First 22 Last

Add OPL (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change 0.002(12.5%)		Mkt cap ! $3.072M

Open	High	Low	Value	Volume
1.6¢	1.8¢	1.6¢	$15.07K	870.8K

Buyers (Bids)

No.	Vol.	Price($)
1	71616	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	245000	1

View Market Depth

No.	Vol.	Price($)
1	71616	0.018
2	1037903	0.016
1	100000	0.015
2	294357	0.014
1	70000	0.013

Price($)	Vol.	No.
0.021	245000	1
0.022	740000	1
0.025	40003	1
0.028	26000	1
0.030	500000	1

Last trade - 11.21am 15/11/2024 (20 minute delay)

OPL (ASX) Chart

Ann: Opyl develops clinical trial prediction software using AI, page-22

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Banshee's historic trenches prove rich in antimony and gold for GDM

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Opyl develops clinical trial prediction software using AI, page-22

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Banshee's historic trenches prove rich in antimony and gold for GDM

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News